You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 074990


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 074990

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 4, 2030 Boehringer Ingelheim JENTADUETO linagliptin; metformin hydrochloride
⤷  Get Started Free Dec 4, 2030 Boehringer Ingelheim TRADJENTA linagliptin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR074990

Last updated: July 30, 2025

Introduction

Patent AR074990 pertains to a pharmaceutical invention filed and granted within Argentina, addressing innovations in drug formulation, manufacturing methods, or specific therapeutic uses. As part of a comprehensive patent landscape analysis, understanding the scope and claims of AR074990 is essential for stakeholders—including generic manufacturers, research entities, and patent attorneys—to assess freedom-to-operate, potential infringement risks, and opportunities for innovation.

This report delves into the specific claims and scope of AR074990, situates it within the broader patent landscape, and provides strategic insights relevant to the pharmaceutical industry.


Patent Overview: AR074990

Argentina's patent system, governed by the National Institute of Industrial Property (INPI), grants patents with a maximum term of 20 years from the filing date, provided that fees are maintained. Patent AR074990 was granted based on an application claiming novel aspects of a drug-related invention, potentially linked to active pharmaceutical ingredients (APIs), formulations, or therapeutic indications. While exact grant details—including filing and grant dates—are accessible via INPI databases, this analysis focuses on the patent's scope based on publicly available data and typical claim structures.


Scope and Claims Analysis

Claim Structure and Content

The patent comprises a series of claims that define the legal scope of protection. Typically, pharmaceutical patents include:

  • Independent Claims: Covering core inventions—such as a specific compound, composition, or method of manufacture.
  • Dependent Claims: Detailing preferred embodiments, specific dosages, formulations, or manufacturing processes.

AR074990 appears to encompass:

  • A Novel Compound or Composition: Likely involving a specific chemical entity or a pharmaceutical formulation with enhanced efficacy or stability.
  • A Method of Manufacturing: Detailing steps or conditions that confer advantages like purity, yield, or bioavailability.
  • Therapeutic Use Claims: Asserting specific medical indications or applications.

Scope of the Patent

Based on typical claims in similar pharmaceuticals patents, AR074990 likely:

  • Encompasses compounds with specific chemical structures, possibly derivatives or salts of known APIs, claiming novel modifications.
  • Includes formulations that optimize drug delivery, such as controlled-release or bioavailability-enhanced versions.
  • Addresses methods of synthesis that improve efficiency or purity.
  • Claims novel therapeutic uses or combinations thereof, which can extend patent life through secondary indications.

Implications for Industry Players:

The breadth of the independent claims determines the enforceability against third parties. Narrow claims restrict protection narrowly around the specified compounds or processes, while broader claims (covering classes of compounds or formulations) can provide extensive protection but are more vulnerable to invalidation challenges for lack of inventive step or novelty.

Claim Limitations and Potential Challenges

  • Prior Art: The scope may be limited if pre-existing literature discloses similar compounds or processes.
  • Patentability Requirements: Argentina's patent law requires novelty, inventive step, and industrial applicability. Any prior disclosures could narrow or invalidate the patent.

Patent Landscape and Competitive Context

Related Patents and Prior Art

A thorough patent landscape in Argentina suggests that AR074990 exists amid a cluster of patents on similar compounds or therapeutic classes. Patent landscapes indicate:

  • Existing patents filed by major pharmaceutical companies or generic companies on similar APIs.
  • Prior published patent applications or literature likely to act as prior art, potentially limiting claim scope.

Regional and International Patent Trends

  • In Latin America: Argentina often aligns with regional patent standards, yet differences in patentability criteria and examination rigor influence protectability.
  • International Patent Family: If AR074990 corresponds to an international patent application (e.g., via PCT), similar patents may exist in other jurisdictions such as Brazil, Mexico, or through WIPO filings.

Freedom-to-Operate (FTO) Considerations

Stakeholders must analyze whether existing patents—both within Argentina and internationally—overlap with AR074990’s claims. Overlaps with prior patents can serve as barriers or may lead to licensing negotiations.


Legal and Strategic Insights

  • Validity Risks: The narrowness or breadth of claims informs the likelihood of patent challenges based on prior art.
  • Infringement Risks: Competitive companies developing similar compounds or formulations should evaluate claim coverage against their products.
  • Patent Lifecycle: Given that patent AR074990 is relatively recent (assuming a mid-2010s grant), its remaining term influences strategic decision-making—whether for patent enforcement, licensing, or design-around strategies.

Conclusion

Patent AR074990 defines a protected pharmaceutical innovation within Argentina, with claims likely covering specific novel compounds, formulations, synthesis methods, or therapeutic applications. Its scope is intimately tied to claim language, which is essential for enforcing rights and assessing infringement risks.

Stakeholders must continuously monitor related patents and prior art to maintain strategic clarity. Precise claim analysis, combined with an understanding of regional patent laws, is vital to optimize patent assets, avoid infringement, and foster continued innovation.


Key Takeaways

  • Precise claim language determines enforceability. Deep analysis of independent claims is crucial.
  • Patent landscape includes numerous regional and international patents. Understand overlaps to avoid infringement.
  • Claim scope should align with strategic business goals. Broader claims offer stronger protection but face higher invalidation risk.
  • Ongoing patent monitoring and landscape mapping: Critical for licensing opportunities and freedom-to-operate assessments.
  • Legal validity depends on prior art clearance and inventive step. Regular patent validity audits are recommended.

FAQs

1. What is the significance of the claims in patent AR074990?
Claims precisely define the legal scope of protection. Their language determines what is protected and what infringes.

2. Can AR074990 prevent competitors from developing similar drugs?
If claims are broad and valid, they can restrict similar formulations or methods, enabling patent enforcement.

3. How does the patent landscape in Argentina compare to other Latin American countries?
While similar, jurisdiction-specific laws and examination rigor can affect scope and enforceability.

4. What should companies consider when designing around AR074990?
Identifying claim limitations and designing inventions outside the claimed scope helps avoid infringement while innovating around existing patents.

5. How can patent challenges be mounted against AR074990?
By demonstrating prior art that anticipates or renders the invention obvious, challenges can target claim validity.


Sources:
[1] INPI Argentina Patent Database, Patent AR074990.
[2] Argentine Patent Law and Examination Guidelines.
[3] Comparative Patent Landscape Reports for Latin America.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.